NEOS Investment Management LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

NEOS Investment Management LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 152,438 shares of the medical equipment provider’s stock after acquiring an additional 57,444 shares during the quarter. NEOS Investment Management LLC’s holdings in Intuitive Surgical were worth $68,175,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Tobam increased its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC purchased a new stake in Intuitive Surgical during the second quarter worth $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical during the third quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical in the second quarter valued at $30,000. Finally, Guerra Advisors Inc acquired a new position in shares of Intuitive Surgical in the third quarter worth about $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.5%

NASDAQ:ISRG opened at $485.84 on Tuesday. The stock has a 50 day moving average of $540.00 and a two-hundred day moving average of $510.44. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08. The firm has a market cap of $172.54 billion, a P/E ratio of 61.58, a price-to-earnings-growth ratio of 3.76 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the previous year, the company posted $2.21 earnings per share. The business’s revenue was up 18.8% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Daiwa Securities Group increased their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Sanford C. Bernstein increased their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Jefferies Financial Group raised their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Finally, Rothschild & Co Redburn increased their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 56,189 shares of company stock worth $30,785,441. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.